Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction

Author： Manna Claudio   Rahman A   Sbracia M   Pappalardo S   Mohamed EI   Linder R   Nardo LG  

Publisher： Informa Healthcare

ISSN： 1473-0766

Source： Gynecological Endocrinology, Vol.20, Iss.4, 2005-04, pp. : 188-194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone

By Messinis IE  

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2415-2420

Oxford University Press

Access to resources Recommend Favorite

Effect of profound suppression of luteinizing hormone during treatment with gonadotrophin-releasing hormone analogue and purified follicle stimulating hormone upon development of cryopreserved embryos

By Rekha P   Mowat L   Jamieson ME   Yates RWS   Fleming R  

Human Reproduction, Vol. 13, Iss. 3, 1998-03 ,pp. : 696-698

Oxford University Press

Access to resources Recommend Favorite

A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon®).

By ganirelix dose-finding study group The  

Human Reproduction, Vol. 13, Iss. 11, 1998-11 ,pp. : 3023-3031

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. The value of basal serum follicle stimulating hormone, luteinizing hormone and oestradiol concentrations following pituitary down-regulation in predicting ovarian response to stimulation with highly purified follicle stimulating hormone*

By Develioglu O.H.   Cox B.   Toner J.P.   Oehninger S.  

Human Reproduction, Vol. 14, Iss. 5, 1999-05 ,pp. : 1168-1174

Oxford University Press

Access to resources Recommend Favorite

Infertility. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial

By Borm G.   Mannaerts B.  

Human Reproduction, Vol. 15, Iss. 7, 2000-07 ,pp. : 1490-1498

Oxford University Press

Access to resources Recommend Favorite